Gender Female
Dr. Mo worked as a physician in one of the leading hospitals in China, where she was frustrated by the lack of effective treatments available for so many of the severe diseases she was treating. This frustration led to a transition from clinical practice to scientific and translational research, where she spent 6 years in postdoctoral roles
studying clinical immunology and eventually joined the pharmaceutical industry. Her research produced several peer-reviewed publications in immunology and oncology and subsequently a drug candidate that completed a successful Phase II in Inflammatory Bowel Disease. She co-founded Aluda with a dedication to using leading-edge biology and a company structure designed for rapid decision-making to discover transformative therapeutics for people living with severe diseases. In her role as CMO for Aluda, she brings knowledge and experience in drug development through proof of concept in the clinic, as well as a sense of urgency as a treating physician.
